Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    ISSN: 1432-1238
    Keywords: Key words Severe CAP ; Pneumococcal pneumonia ; Prognosis on ICU
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract Objective: To describe risk factors of severe pneumococcal community-acquired pneumonia and to study variables influencing outcome. Design: Retrospective (1987–1992) and prospective (1993–1995) study. Setting: Three participating ICUs from primary care hospitals. Patients: Five hundred and five patients (mean age: 63 ± 17 years) with severe community-acquired pneumonia (CAP). Three groups of patients were defined: pneumococcal CAP (group 1), CAP with microbial diagnosis other than Streptococcus pneumoniae (group 2), CAP from group 2 and CAP without microbial diagnosis (group 3). Measurements and results: Admission data and data on the disease's course were recorded. The mean Simplified Acute Physiologic Score (SAPS) was 12.5 ± 5.4. On admission 288 (57 %) patients were mechanically ventilated (mv) and 82 (16.2 %) required inotropic support. A microbial diagnosis was established for 309 (61.2 %) patients. S. pneumoniae was isolated in 137 (27.1 %) patients. Severe pneumococcal CAP was independently associated with male sex (p = 0.01), lack of antibiotics use before admission (p = 0.0001), non-aspiration pneumonia (p = 0.01) and septic shock (p = 0.0001). The overall mortality rate was 27.5 % (29.2 % in group 1). In patients with severe pneumococcal CAP, multivariate analysis showed that leukopenia less than 3,500/mm3 (p = 0.0004), age over 65 years (p = 0.01), septic shock (p = 0.01), sepsis related complications (p = 0.0001), ICU complications (p = 0.001) and inadequacy of antimicrobial therapy (p = 0.002) worsened the prognosis. Conclusions: Few features facilitate the identification of pneumococcal CAP on ICU admission. The prognosis is mostly related to severity of illness (leukopenia, septic shock) while comorbidities do not seem to influence outcome. Sepsis-related disorders, ICU complications and adequate antimicrobial chemotherapy are the major variables affecting the outcome during an ICU stay.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    Electronic Resource
    Electronic Resource
    Springer
    Intensive care medicine 19 (1993), S. 347-350 
    ISSN: 1432-1238
    Keywords: Vancomycin ; Pharmocokinetics ; Continuous hemodiafiltration ; Acute renal failure
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract Objective To study the pharmacokinetics of vancomycin in three patients with acute renal failure related to multi-organ failure during continous venovenous hemodiafiltration (CVVHD). Design: Prospective exploratory, open-labelled study. Setting Critical Care Unit in a University Medical Centre. Patients 3 patients exhibiting hemodynamic instability and oligo-anuric acute renal failure requiring extra-renal epuration were included in this study. Intervention Every patient received 7.5 mg/kg IV vancomycin over 1 h for a documented or suspected nosocomial staphylococcal infection. Serum and dialysate outlets samples were collected before infusion and 1, 3, 6, 12, 18, 24 after the end of infusion. Measurements and results Mean age was 58.7 years (range 41–79) and mean SAPS 15.7 (9–23). The mean peak concentrations were 27.3 mg/l (range 15.6–45.6) one hour after the end of infusion. The average remaining vancomycin concentration 24 h after the onset of infusion was 3.6 mg/I (range 2.6–4.5). The mean terminal disposition rate constant and elimination half-life were 0.05 h−1 and 13.9 h respectively. Mean total body clearance was 38.9±4.3 ml/min and dialysate outlet (DO) clearance 4.2±1.3 ml/min. The mean volume of distribution was 47.4±6.4 l. Conclusion CVVHD is effective for vancomycin elimination. In these patients, the elimination half-life is almost constant, involving a following injection of vancomycin 12 h later to achieve effective concentrations.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...